1,0
2 jun 2010
Anonieme werknemer
Huidige werknemer
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
the things that are left are still valuable (but doubtless outsourced soon) it's not as bad as other pharma atm you can still get science done if you try
Minpunten
everything is done to a cost, regardless, and you get what you pay for people are waiting for a payout success in spite of not because of